公开(公告)号：EP4414037A3

公开(公告)日：2024-08-21

申请号：EP24165019.1

申请日：2017-09-15

申请人： Nippon Chemiphar Co., Ltd.

发明人： NAGASE, Hiroshi ,  FUJII, Hideaki ,  SAITOH, Akiyoshi ,  NAKATA, Eriko ,  HIROSE, Masaaki ,  OOI, Isao ,  HAYASHIDA, Kohei

IPC分类号： A61K31/485 ,  A61K31/439 ,  A61K31/444 ,  A61K31/4709 ,  A61K31/497 ,  A61K31/501 ,  A61K31/506 ,  A61P21/00 ,  A61P25/04 ,  A61P25/06 ,  A61P25/22 ,  A61P25/24 ,  A61P43/00

CPC分类号： A61K31/439 ,  A61K31/444 ,  A61K31/4709 ,  A61K31/497 ,  A61K31/501 ,  A61K31/506 ,  A61P25/24 ,  A61P25/04 ,  A61P21/00 ,  A61P25/22 ,  A61P25/06 ,  A61P43/00 ,  A61K31/485

摘要： The present invention relates to a pharmaceutical composition comprising a morphinan derivative that exhibits an opioid δ receptor agonist activity. By administering the pharmaceutical composition provided by the present invention, opioid δ receptor-related diseases (for example, a depression as a symptom associated with Alzheimer's disease) can be treated or prevented.